News & Updates

Pan-enteric capsule endoscopy accurately diagnoses IBD
Pan-enteric capsule endoscopy accurately diagnoses IBD
10 Oct 2022
SGLT2i does not worsen lower-limb amputation risk
SGLT2i does not worsen lower-limb amputation risk
10 Oct 2022

Among patients with type 2 diabetes (T2D), the use of sodium-glucose cotransporter 2 inhibitors {SGLT2i) does not appear to increase the risk of lower-limb amputation, a recent study has found.

SGLT2i does not worsen lower-limb amputation risk
10 Oct 2022
Does age at diagnosis affect diabetes outcomes?
Does age at diagnosis affect diabetes outcomes?
09 Oct 2022 byRoshini Claire Anthony

Individuals who are diagnosed with type 2 diabetes (T2D) at age 40 years have a greater risk of cardiovascular disease (CVD) and mortality than same-aged individuals without T2D or individuals diagnosed with T2D in later life, according to a study from Korea presented at EASD 2022.

Does age at diagnosis affect diabetes outcomes?
09 Oct 2022
Plasma glutamate, amino acid profiles altered in type 1 diabetes
Plasma glutamate, amino acid profiles altered in type 1 diabetes
09 Oct 2022

Among patients with type 1 diabetes (T1D), alterations in plasma glutamate levels and free amino acid profiles are distinct than that in type 2 diabetes (T2D) patients and healthy controls, a recent study has found.

Plasma glutamate, amino acid profiles altered in type 1 diabetes
09 Oct 2022
Bronchodilators ineffective in symptomatic, tobacco-exposed patients without COPD
Bronchodilators ineffective in symptomatic, tobacco-exposed patients without COPD
08 Oct 2022 byRoshini Claire Anthony

Bronchodilators, used in the treatment of chronic obstructive pulmonary disease (COPD), did not appear to benefit individuals with a history of smoking and respiratory symptoms who did not have airflow obstruction, results of the US-based RETHINC* study showed.

Bronchodilators ineffective in symptomatic, tobacco-exposed patients without COPD
08 Oct 2022